Hypersensitivity and Basal cell carcinoma

Summary:

Basal cell carcinoma is found among people with Hypersensitivity, especially for people who are female, 60+ old.

The study analyzes which people have Basal cell carcinoma with Hypersensitivity. It is created by eHealthMe based on reports of 121 people who have Hypersensitivity from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hypersensitivity?

Hypersensitivity is found to be associated with 2,749 drugs and 2,916 conditions by eHealthMe. Check the latest studies of Hypersensitivity.

What is Basal cell carcinoma?

Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills) is found to be associated with 1,092 drugs and 1,381 conditions by eHealthMe. Check the latest studies of Basal cell carcinoma.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

121 people who have Hypersensitivity and Basal Cell Carcinoma are studied.

Would you have Basal cell carcinoma when you have Hypersensitivity?

Gender of people who have Hypersensitivity and experienced Basal cell carcinoma *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Basal cell carcinoma?

- Check whether Basal cell carcinoma is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Hypersensitivity (272,618 reports)
Basal cell carcinoma (26,984 reports)

All the drugs that are associated with Basal cell carcinoma:

Basal cell carcinoma (1,092 drugs)

All the conditions that are associated with Basal cell carcinoma:

Basal cell carcinoma (1,381 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Basal cell carcinoma and Hypersensitivity, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.